A multi-center cohort study Examining risk factors for central nervous system metastases (CNSm) in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive chemoradiation (ChemoRT) followed by durvalumab (Durva).
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: John Sharp, Philip Young, Songzhu Zhao, Sandip Pravin Patel, Lai Wei, Mingjia Li, Jeremy Brownstein, Karl Haglund, Joshua David Palmer, Raju R. Raval, Peter G. Shields, Kai He, Jacob Kaufman, Regan Michelle Memmott, Asrar Alahmadi, David Paul Carbone, Gregory Alan Otterson, Carolyn J. Presley, Ryan D. Gentzler, Dwight Hall Owen
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4400037360